文献速递临床生化临床免疫

微流液相色谱-串联质谱法多重定量人血浆PP折叠家族肽

Multiplexed Assay to Quantify the PP-Fold Family of Peptides in Human Plasma Using Microflow Liquid Chromatography-Tandem Mass Spectrometry.
PubMed 文献 · Clin Chem · 2022-01-01

研究开发了免疫捕获结合微流UHPLC-MS/MS的多重同位素稀释法,可同时定量PYY1-36、PP1-36、NPY1-36及其DPP4代谢物PYY3-36、PP3-36、NPY3-36。方法线性良好(r²>0.99),LLOQ为0.5-3.0 pM,批内批间偏差和 imprecision <21%。健康志愿者样本中PYY3-36、NPY3-36、PP1-36和PP3-36有43%-100%高于LLOQ,而PYY1-36和NPY1-36分别仅9%和0%高于LLOQ。与免疫测定相比,免疫测定浓度更高且一致性差。

要点

  • 该多重质谱法可同时定量PP折叠家族6种肽,LLOQ低至0.5-3.0 pM。
  • 健康人血浆中PYY1-36和NPY1-36多低于LLOQ,而3-36片段更易检出。
  • 免疫测定与质谱法一致性差且浓度偏高,临床解读需注意方法差异。

核心结论

  • 该微流UHPLC-MS/MS多重免疫捕获法可特异定量PP折叠家族肽及其DPP4切割片段,为研究其在健康和代谢疾病中的作用提供新工具。

研究设计与样本

  • 研究开发了多重同位素稀释免疫捕获结合微流UHPLC-MS/MS的检测方法,并从健康志愿者采集空腹和营养刺激后30分钟的血样进行方法验证和比较。

主要发现

  • 在测量区间内线性良好(r² > 0.99)。
  • PYY1-36和PYY3-36的LLOQ(CV 20%)为1.5 pM,PP1-36和PP3-36为3.0 pM,NPY1-36为0.8 pM,NPY3-36为0.5 pM。
  • 所有情况下批内和批间偏差及不精密度均<21%。
  • 健康志愿者样本中PYY3-36、NPY3-36、PP1-36和PP3-36有43%至100%高于LLOQ,PYY1-36有9%高于LLOQ,NPY1-36有0%高于LLOQ。
  • 与微流UHPLC-MS/MS相比,免疫测定显示待测物浓度更高且一致性差。

临床怎么用

  • 该法可用于单样本同时分析PP折叠家族肽及其DPP4切割片段,支持代谢疾病研究和治疗潜力评估。
  • 分析前需加入蛋白酶抑制剂混合物以保证肽的稳定性。
  • 临床解读时应注意免疫测定与质谱法结果差异大,免疫测定浓度偏高。

局限性

  • 原文未明确报告方法的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peptide Tyr-Tyr (PYY1-36), pancreatic polypeptide (PP1-36) and neuropeptide Y (NPY1-36) constitute the PP-fold family of peptides that is involved in metabolic regulation. Very low plasma concentrations and cleavage into active 3-36 fragments challenge bioanalytical assays used for the quantification of these peptides. METHODS: We developed a multiplexed isotopic dilution assay to quantify PYY1-36, PP1-36, and NPY1-36 and their dipeptidyl peptidase-4 (DPP4)-derived metabolites PYY3-36, PP3-36 and NPY3-36. All peptides were immunocaptured from plasma using a monoclonal antibody and quantified by micro-ultra-HPLC-MS/MS. Blood samples from healthy volunteers were collected fasting and 30 min after nutrient stimulation. Method comparison was performed with commercial immunoassays. RESULTS: Linearity was shown in the measured intervals (r2 > 0.99). The lower limit of quantification (LLOQ) with a CV at 20% was 1.5 pM for PYY1-36 and PYY3-36, 3.0 pM for PP1-36 and PP3-36, 0.8 pM for NPY1-36 and 0.5 pM for NPY3-36. In all cases, intra- and inter-assay bias and imprecision were <21%. Pre-analytical stability required addition of a protease inhibitor cocktail. Physiological concentrations of PYY3-36, NPY3-36, PP1-36 and PP3-36 were above the LLOQ in 43% to 100% of the samples. PYY1-36 and NPY1-36 were above the LLOQ in 9% and 0% of the samples, respectively. Immunoassays showed higher concentrations of measurands and poor agreement when compared with micro-UHPLC-MS/MS. CONCLUSIONS: The assay allowed for specific multiplexed analysis of the PP-fold family of peptides and their DPP4-cleaved fragments in a single sample, thereby offering new perspectives to study the role and therapeutic potential of these essential peptide hormones in health and metabolic disease.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Reverter-Branchat G, Eugster PJ, Kuenzli C, et al. Multiplexed Assay to Quantify the PP-Fold Family of Peptides in Human Plasma Using Microflow Liquid Chromatography-Tandem Mass Spectrometry. Clin Chem. 2022. PMID: 35015868. doi:10.1093/clinchem/hvab229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。